National survey on prescription of cardiovascular drugs among outpatients with coronary artery disease in Switzerland.

Détails

Ressource 1Télécharger: 12644962.pdf (246.61 [Ko])
Etat: Serval
Version: Final published version
ID Serval
serval:BIB_F2427474079B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
National survey on prescription of cardiovascular drugs among outpatients with coronary artery disease in Switzerland.
Périodique
Swiss medical weekly
Auteur(s)
Muntwyler J., Noseda G., Darioli R., Gruner C., Gutzwiller F., Follath F.
ISSN
1424-7860 (Print)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
08/02/2003
Peer-reviewed
Oui
Volume
133
Numéro
5-6
Pages
88-92
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Secondary prevention of coronary artery disease markedly reduces cardiovascular mortality and non-fatal endpoints. Outpatient care of subjects with coronary artery disease has been assessed in several European countries, but no current data is available for Switzerland.
A random sample of office-based physicians across Switzerland recorded current drug prescription of outpatients with coronary artery disease in the years 2000/2001 by means of a mail questionnaire. We assessed treatment frequencies according to different patient characteristics.
565 patients were included (mean age 68 +/- 11 years, 75% male). There was no evidence for differences in drug utilisation among the regions. Drug prescription rates for antithrombotic agents, beta-blockers, ACE-inhibitors/angiotensin receptor blockers and lipid lowering drugs were 91%, 58%, 50% and 63% respectively. Lower treatment rates were observed among patients >70 years and in those without a history of myocardial infarction or coronary revascularisation. Forty-nine percent of the patients had a blood pressure >140/>90, and 60% had lipid readings above the intervention cut-off according to the Swiss recommendations. Among those without a history of myocardial infarction or coronary revascularisation, the respective figures were 60% and 80%.
Compared to former surveys evidence based drug prescription has improved in Switzerland. Despite this, therapeutic goals for cholesterol levels and blood pressure are not being reached in a large proportion of patients. A high risk group for under use of evidence based drugs are patients without a history of myocardial infarction or coronary revascularisation.

Mots-clé
Adrenergic beta-Antagonists/therapeutic use, Aged, Ambulatory Care/statistics & numerical data, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Blood Pressure/drug effects, Cardiovascular Agents/therapeutic use, Cholesterol/blood, Coronary Artery Disease/blood, Coronary Artery Disease/drug therapy, Coronary Artery Disease/physiopathology, Drug Prescriptions/statistics & numerical data, Drug Utilization/statistics & numerical data, Female, Fibrinolytic Agents/therapeutic use, Health Care Surveys, Humans, Hypolipidemic Agents/therapeutic use, Male, Population Surveillance, Switzerland/epidemiology
Pubmed
Web of science
Création de la notice
28/01/2008 12:45
Dernière modification de la notice
11/06/2018 12:36
Données d'usage